In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Breaking up mergers after the fact: Opportunities and problems
Antitrust authorities in both the United States and Europe have recently shown an increased interest in reviewing past mergers with the objective of possibly...